LeMaitre Vascular (LMAT) Stock Price

LeMaitre Vascular Price

NASDAQ·CLOSED
77.65
​
Market closed

Over the last 19 years LeMaitre Vascular grew revenue by 11.0% annually, reaching 249.60 M USD. Earnings per share have grown at 22.2% per year over the last 16 years. For LeMaitre Vascular, the net margin of 23.1% is up versus 17.4% a few years ago. At today's price the dividend yield works out to roughly 1.03%. The payout ratio is around 32% of earnings. The dividend has grown at 17.9% per year over the past 14 years. The consensus 12-month price target for LeMaitre Vascular is 115.00 USD, about 48.1% above where the stock trades today. Of 14 analysts, 9 rate the stock a buy — an overall Buy consensus.

LeMaitre Vascular stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LeMaitre Vascular business model & stock analysis

LeMaitre Vascular Inc. is a global company that specializes in the development and marketing of medical devices and instruments for the diagnosis, treatment, and prevention of peripheral vascular diseases. The company was founded in 1983 by George D. LeMaitre, a former heart surgeon, with the goal of providing innovative and high-quality medical devices that meet the needs of patients and healthcare professionals. LeMaitre Vascular Inc. has become a leading provider of medical devices and instruments for the vascular surgical community and has offices worldwide. The company's business model focuses on the development and marketing of medical devices for peripheral vascular diseases, with an emphasis on quality, innovation, and effectiveness. LeMaitre Vascular Inc. collaborates with medical research institutions and clinicians to develop new products and improve existing ones. The company operates in three main areas: vascular access, endovascular, and surgery. LeMaitre Vascular Inc. offers a wide range of products for the diagnosis, treatment, and prevention of peripheral vascular diseases. Some of the main products include Avflo, Heparinase, XenoSure Aspirating Siphon, Dinamik, and Valvulotome. Overall, LeMaitre Vascular Inc. is committed to meeting the needs of healthcare professionals and patients and will continue to develop its products accordingly.

Frequently asked questions about LeMaitre Vascular

The business model of LeMaitre Vascular Inc is focused on designing, manufacturing, and marketing medical devices used in the treatment of peripheral vascular disease. The company primarily focuses on products related to the treatment of arteries and veins outside of the heart, including bypass graft surgery, carotid surgery, and dialysis access procedures. LeMaitre Vascular offers a wide range of products, including grafts, balloons, stents, and surgical laser consoles, among others. By providing innovative and high-quality medical devices, LeMaitre Vascular aims to improve patient outcomes and establish itself as a leader in the peripheral vascular market.

LeMaitre Vascular Inc is primarily active in the medical equipment and supplies industry.

The main competitors of LeMaitre Vascular Inc in the market are Medtronic, Boston Scientific Corporation, and Edwards Lifesciences Corporation.

LeMaitre Vascular Inc, founded in 1983, is a leading provider of medical devices for the treatment of peripheral vascular disease. With its headquarters in Burlington, Massachusetts, the company specializes in the design, manufacturing, and distribution of innovative products used in vascular surgery. LeMaitre Vascular offers a comprehensive range of devices, including grafts, catheters, and implants, to address various vascular conditions. Over the years, the company has grown its presence globally, serving healthcare professionals and patients in more than 80 countries. LeMaitre Vascular Inc's commitment to excellence, continuous innovation, and focus on improving patient outcomes has solidified its position as a trusted leader in the vascular healthcare industry.

LeMaitre Vascular Inc has achieved several significant milestones. The company has successfully expanded its product portfolio, introducing innovative solutions in the field of vascular surgery. LeMaitre Vascular has also made notable strides in global market expansion, establishing a strong presence in over 85 countries. Furthermore, the company has demonstrated consistent revenue growth and a commitment to enhancing patient outcomes through continuous research and development efforts. With its dedication to improving vascular care and its consistent track record of success, LeMaitre Vascular Inc has solidified its position as a leading provider in the medical device industry.

LeMaitre Vascular Inc is primarily present in the United States, Canada, Europe, and Asia.

LeMaitre Vascular Inc represents a set of core values and a strong corporate philosophy. The company is committed to innovation, providing high-quality medical devices, and improving patient outcomes. LeMaitre Vascular focuses on delivering superior products in the field of vascular surgery and strives to address unmet clinical needs. Their emphasis on research and development reflects their dedication to advancing medical technology. With a customer-centric approach, LeMaitre Vascular aims to build lasting relationships with healthcare professionals and achieve sustainable growth. By prioritizing excellence, integrity, and teamwork, LeMaitre Vascular Inc demonstrates its commitment to improving vascular care worldwide.

Analysts currently set an average price target of 115.00 USD for the LeMaitre Vascular stock (median: 115.00 USD), implying +46.9 % versus the latest price. The consensus is based on 14 analyst ratings.

14 analysts currently rate the LeMaitre Vascular stock: 9 recommend buying, 5 holding and 0 selling. For 2026, analysts expect LeMaitre Vascular to generate revenue of 276.03 M USD and earnings per share of 2.77 USD.

Converted at the current exchange rate, the LeMaitre Vascular share trades at 70.40 EUR (77.65 USD).

The LeMaitre Vascular share (LMAT) is listed on 3 stock exchanges, including: NASDAQ (LMAT), Frankfurt (LHU.F), München (LHU.MU).

LeMaitre Vascular Inc is a leading medical company specializing in the development and marketing of medical devices for the treatment of vascular diseases. The company is headquartered in the USA and has branches worldwide. LeMaitre Vascular's business model focuses on manufacturing specialized medical devices used in vascular surgery. The company offers a wide range of innovative products that contribute to improving the quality of life for patients with vascular diseases. One important sector of LeMaitre Vascular is the production of endoprostheses used to treat vessel occlusions or stenosis. The company also offers a wide range of balloon catheters that can be used to dilate narrowed or blocked vessels. Another key area of the company's business is the manufacturing of venous valves used in the treatment of venous diseases and chronic venous insufficiency. These products have proven to be highly effective and provide long-term relief for patients. In addition to manufacturing medical devices, LeMaitre Vascular also offers a wide range of services. The company is known for its high-quality customer service, working closely with doctors and medical professionals to ensure the effective use of their products. To further promote its growth, LeMaitre Vascular invests in research and development. The company has a team of talented researchers and developers focused on creating innovative devices and medical solutions that contribute to improving patient care. In recent years, LeMaitre Vascular has also established an increasing presence in the international market. The company has opened branches in Europe, Asia, and the Middle East to expand the reach of its products and grow its business in new markets. In summary, the business model of LeMaitre Vascular aims to manufacture innovative medical devices that contribute to improving the lives of patients with vascular diseases. The company offers a wide range of products and services, including endoprostheses, venous valves, and balloon catheters. LeMaitre Vascular is also a pioneer in research and development and strategically expanding its presence in the international market.

The expected revenue of LeMaitre Vascular is 276.03 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of LeMaitre Vascular is 63.67 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of LeMaitre Vascular is currently 28.01. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the LeMaitre Vascular stock.

The price-to-sales ratio (P/S) of LeMaitre Vascular is currently 6.46. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the LeMaitre Vascular stock.

The Eulerpool Quality Score for LeMaitre Vascular is 8/10.

The ISIN of LeMaitre Vascular is US5255582018. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of LeMaitre Vascular is A0LB2B. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of LeMaitre Vascular is LMAT. The ticker symbol is used to trade LeMaitre Vascular shares on the stock exchange.

Fair ValueTerminal
72.99 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
386,380.80 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website lemaitre.com
Currency
USD
Initial public offering
Oct 19, 2006
ISIN
US5255582018
Cusip
525558201
Sedol
B1G6TJ0
Market capitalization
1.76 B USDSmall Cap
52-Week Range
PEG
4.35
P/E ratio
P/Ee 2026
27.67
P/Ee 2027
24.65
P/Ee 2028
22.52
P/Ee 2029
—
P/S
P/Se
6.46
EV/EBIT
28.26
P/B Ratio
4.48
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.97 %
Dividend
Dividend yield
1.03 %
Est. Dividend Yield
1.29 %
Payout Ratio
31.83 %
Dividend growth Ø5Y
14.87 %
Dividend payments per year
4
Dividend paid since
15 years
Dividend not reduced since
15 years
Dividend increased since
15 years
Dividend withholding tax
30.00 %
Last updated Nov 16, 2026, 3:39 AM

LeMaitre Vascular Ticker

FRANKFURT · LHU.FMUNICH · LHU.MUNASDAQ · LMAT

LeMaitre Vascular FIGI

LMAT:US · BBG000LY1HS2LMAT:UA · BBG000LY1KF9LMAT:UC · BBG000LY1LC0LMAT:UN · BBG000LY1NN4LMAT:UP · BBG000LY1PN9LMAT:UQ · BBG000LY1QM8LMAT:UB · BBG000LY1R73LMAT:UM · BBG000LY1SN3LMAT:UX · BBG000LY1T97LMAT:UD · BBG000LY1XK5LMAT:UF · BBG000LY2197LMAT:VY · BBG000LY21L3